BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32733644)

  • 1. Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors
    Xu EY; Vosburgh E; Wong C; Tang LH; Notterman DA
    Oncotarget; 2020 Jul; 11(28):2718-2739. PubMed ID: 32733644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two well-differentiated pancreatic neuroendocrine tumor mouse models.
    Wong C; Tang LH; Davidson C; Vosburgh E; Chen W; Foran DJ; Notterman DA; Levine AJ; Xu EY
    Cell Death Differ; 2020 Jan; 27(1):269-283. PubMed ID: 31160716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice.
    Loffler KA; Biondi CA; Gartside MG; Serewko-Auret MM; Duncan R; Tonks ID; Mould AW; Waring P; Muller HK; Kay GF; Hayward NK
    Oncogene; 2007 Jun; 26(27):4009-17. PubMed ID: 17173065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue- and cell-specific properties of enterochromaffin cells affect the fate of tumorigenesis toward nonendocrine adenocarcinoma of the small intestine.
    Sei Y; Feng J; Zhao X; Dagur P; McCoy JP; Merchant JL; Wank SA
    Am J Physiol Gastrointest Liver Physiol; 2023 Mar; 324(3):G177-G189. PubMed ID: 36537709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN Loss Expands the Histopathologic Diversity and Lineage Plasticity of Lung Cancers Initiated by Rb1/Trp53 Deletion.
    Zhang L; Liu C; Zhang B; Zheng J; Singh PK; Bshara W; Wang J; Gomez EC; Zhang X; Wang Y; Zhu X; Goodrich DW
    J Thorac Oncol; 2023 Mar; 18(3):324-338. PubMed ID: 36473627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
    Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
    Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex Vivo Organoid Model of Adenovirus-Cre Mediated Gene Deletions in Mouse Urothelial Cells.
    Xu D; Wang L; Wieczorek K; Wang Y; Zhang X; Goodrich DW; Li Q
    J Vis Exp; 2022 May; (183):. PubMed ID: 35604166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Trp53 and Rb1 in Ctsk-expressing cells drives osteosarcoma progression by activating glucose metabolism and YAP signaling.
    Li Y; Yang S; Liu Y; Yang S
    MedComm (2020); 2022 Jun; 3(2):e131. PubMed ID: 35615117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in Mice.
    Filtz EA; Emery A; Lu H; Forster CL; Karasch C; Hallstrom TC
    PLoS One; 2015; 10(8):e0136729. PubMed ID: 26317218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual loss of rb1 and Trp53 in the adrenal medulla leads to spontaneous pheochromocytoma.
    Tonks ID; Mould AW; Schroder WA; Cotterill A; Hayward NK; Walker GJ; Kay GF
    Neoplasia; 2010 Mar; 12(3):235-43. PubMed ID: 20234817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues.
    Biondi CA; Gartside MG; Waring P; Loffler KA; Stark MS; Magnuson MA; Kay GF; Hayward NK
    Mol Cell Biol; 2004 Apr; 24(8):3125-31. PubMed ID: 15060136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors.
    Yamauchi Y; Kodama Y; Shiokawa M; Kakiuchi N; Marui S; Kuwada T; Sogabe Y; Tomono T; Mima A; Morita T; Matsumori T; Ueda T; Tsuda M; Nishikawa Y; Kuriyama K; Sakuma Y; Ota Y; Maruno T; Uza N; Masuda A; Tatsuoka H; Yabe D; Minamiguchi S; Masui T; Inagaki N; Uemoto S; Chiba T; Seno H
    Cancer Res; 2020 Sep; 80(17):3620-3630. PubMed ID: 32591410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling.
    Mould AW; Duncan R; Serewko-Auret M; Loffler KA; Biondi C; Gartside M; Kay GF; Hayward NK
    Int J Cancer; 2007 Aug; 121(4):776-83. PubMed ID: 17455252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome.
    Dilley WG; Kalyanaraman S; Verma S; Cobb JP; Laramie JM; Lairmore TC
    Mol Cancer; 2005 Feb; 4(1):9. PubMed ID: 15691381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trp53 inactivation leads to earlier phaeochromocytoma formation in pten knockout mice.
    Korpershoek E; Kloosterhof NK; Ziel-van der Made A; Korsten H; Oudijk L; Trapman J; Dinjens WN; de Krijger RR
    Endocr Relat Cancer; 2012 Dec; 19(6):731-40. PubMed ID: 22930559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.
    Yong C; Moose DL; Bannick N; Gutierrez WR; Vanneste M; Svensson R; Breheny P; Brown JA; Dodd RD; Cohen MB; Henry MD
    PLoS One; 2020; 15(9):e0232807. PubMed ID: 32986721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
    Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
    Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Inhibition of the E3 Ligase SCF
    Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
    Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.